Japan holds back OTC sales at Boehringer

15 April 2014 - Deborah Wilkes

Archived

Boehringer Ingelheim's Consumer Health Care division reported worldwide sales down by 2.1% to €1.47 billion (US$2.03 billion) in 2013, as sales in Japan fell by 17.9% to €241 million "due to currency effects".

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: